Depression in systemic lupus erythematosus patients is associated with link-polymorphism but not methylation status of the 5HTT promoter region

Lupus

Volumn 22, Issue 10, 2013, Pages 1001-1010

  Xu, J ^a,b   Cheng, Y Q ^b   Chen, B ^c   Bai, R ^b   Li, S ^b   Xu, X F ^b   Xu, L ^c   Wen, J F ^c   Lu, Z P ^b   Zeng, X F ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

depression; DNA methylation; serotonin transporter linked polymorphism; Systemic lupus erythematosus

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA METHYLATION; EPIGENETICS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAMILTON SCALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS;

DEPRESSION; DNA METHYLATION; SEROTONIN TRANSPORTER-LINKED POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BASE SEQUENCE; CPG ISLANDS; DEPRESSION; DNA METHYLATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84883012217     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313498793     Document Type: Article

References (65)

1. Kremer JM, Rynes RI, Bartholomew LE, et al. Non-organic non-psychotic psychopathology (NONPP) in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1981 ; 11: 182-189
2. Shortall E, Isenberg D, Newman SP. Factors associated with mood and mood disorders in SLE. Lupus. 1995 ; 4: 272-279
3. Omdal R, Husby G, Mellgren SI. Mental health status in systemic lupus erythematosus. Scand J Rheumatol. 1995 ; 24: 142-145
4. Ishikura R, Morimoto N, Tanaka K, et al. Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol. 2001 ; 20: 394-400
5. Hay EM, Black D, Huddy A, et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum. 1992 ; 35: 411-416
6. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001 ; 57: 496-500
7. Nery FG, Borba EF, Hatch JP, Soares JC, Bonfá E, Neto FL. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry. 2007 ; 48: 14-19
8. Gao HX, Campbell SR, Cui MH, et al. Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J Neuroimmunol. 2009 ; 207: 45-56
9. Wang C, Sandling JK, Hagberg N, et al. Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4. Ann Rheum Dis. 2013 ; 72: 96-103
10. Piotrowski P, Lianeri M, Wudarski M, Olesińska M, Jagodziński PP. Contribution of STAT4 gene single-nucleotide polymorphism to systemic lupus erythematosus in the Polish population. Mol Biol Rep. 2012 ; 39: 8861-8866
11. Nicolas CS, Peineau S, Amici M, et al. The Jak/STAT pathway is involved in synaptic plasticity. Neuron. 2012 ; 73: 374-390
12. Oroszi G, Lapteva L, Davis E, et al. The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Ann Rheum Dis. 2006 ; 65: 1330-1335
13. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev. 2007 ; 8: 355-367
14. Kuratomi G, Iwamoto K, Bundo M, et al. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol Psychiatry. 2008 ; 13: 429-441
15. Sun H, Kennedy PJ, Nestler EJ. Epigenetics of the depressed brain: Role of histone acetylation and methylation. Neuropsychopharmacology. 2013 ; 38: 124-137
16. Schroeder M, Krebs MO, Bleich S, Frieling H. Epigenetics and depression: Current challenges and new therapeutic options. Curr Opin Psychiatry. 2010 ; 23: 588-592
17. Peters AH, Schübeler D. Methylation of histones: Playing memory with DNA. Curr Opin Cell Biol. 2005 ; 17: 230-238
18. Jaenisch R, Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet. 2003 ; 33 (Suppl): 245-254
19. Januchowski R, Prokop J, Jagodzinski PP. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet. 2004 ; 45: 237-248
20. Pan Y, Sawalha AH. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res. 2009 ; 153: 4-10
21. Pellegrino TC, Bayer BM. Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release. Neuroimmunomodulation. 2001 ; 8: 179-187
22. Frank MG, Johnson DR, Hendricks SE, Frank JL. Monocyte 5-HT1A receptors mediate pindobind suppression of natural killer cell activity: Modulation by catalase. Int immunopharmacol. 2001 ; 1: 247-253
23. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun. 2000 ; 14: 219-224
24. Lesch KP, Balling U, Gross J, et al. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect. 1994 ; 95: 157-162
25. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996 ; 274: 1527-1531
26. Levinson DF. The genetics of depression: A review. Biol Psychiatry. 2006 ; 60: 84-92
27. Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A meta-analysis. JAMA. 2009 ; 301: 2462-2471
28. Lesch KP, Wolozin BL, Murphy DL, Reiderer P. Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem. 1993 ; 60: 2319-2322
29. Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: Effects of suicide. Arch Gen Psychiatry. 1989 ; 46: 237-241
30. Lawrence KM, Falkowski J, Jacobson RR, Horton RW. Platelet 5-HT uptake sites in depression: Three concurrent measures using [3H] imipramine and [3H] paroxetine. Psychopharmacology (Berl). 1993 ; 110: 235-239
31. Lima L, Urbina M. Serotonin transporter modulation in blood lymphocytes from patients with major depression. Cell Mol Neurobiol. 2002 ; 22: 797-804
32. Lima L, Mata S, Urbina M. Allelic isoforms and decrease in serotonin transporter mRNA in lymphocytes of patients with major depression. Neuroimmunomodulation. 2005 ; 12: 299-306
33. Urbina M, Pineda S, Piñango L, Carreira I, Lima L. [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Int J Immunopharmacol. 1999 ; 21: 631-646
34. Philibert RA, Sandhu H, Hollenbeck N, Gunter T, Adams W, Madan A. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 543-549.
35. van IJzendoorn MH, Caspers K, Bakermans-Kranenburg MJ, Beach SR, Philibert R. Methylation matters: Interaction between methylation density and serotonin transporter genotype predicts unresolved loss or trauma. Biol Psychiatry. 68: 405-407
36. Meyerhoff J, Dorsch CA. Decreased platelet serotonin levels in systemic lupus erythematosus. Arthritis Rheum. 1981 ; 24: 1495-1500
37. Xu J, Zhang G, Cheng Y, et al. Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Lupus. 2011 ; 20: 678-689
38. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
39. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 ; 23: 56-62
40. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism? Human molecular genetics 1997; 6: 2233-2238.
41. Cook EH, Jr., Courchesne R, Lord C, et al. Evidence of linkage between the serotonin transporter and autistic disorder. Molecular psychiatry 1997; 2: 247-250.
42. Lindsey JC, Anderton JA, Lusher ME, Clifford SC. Epigenetic events in medulloblastoma development. Neurosurg Focus. 2005 ; 19: E10 - E10
43. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol. 1987 ; 196: 261-282
44. Noble PB, Cutts JH. Separation of blood leukocytes by Ficoll gradient. Can Vet J. 1967 ; 8: 110-111
45. Kaneda M, Okano M, Hata K, et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature. 2004 ; 429: 900-903
46. Ehrich M, Zoll S, Sur S, van den Boom D. A new method for accurate assessment of DNA quality after bisulfite treatment. Nucleic Acids Res. 2007 ; 35: e29 - e29
47. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA. 1992 ; 89: 1827-1831
48. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994 ; 22: 2990-2997
49. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: Systematic investigation of critical experimental parameters. Nucleic Acids Res. 2001 ; 29: E65-5
50. Zhang Y, Jeltsch A. The application of next generation sequencing in DNA methylation analysis. Genes. 2010 ; 1: 85-101
51. Willeit M, Praschak-Rieder N, Neumeister A, et al. A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol Psychiatry. 2003 ; 8: 942-946
52. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation. Arch Gen Psychiatry. 2011 ; 68: 444-454
53. Otte C, McCaffery J, Ali S, Whooley MA. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: The Heart and Soul Study. Am J Psychiatry. 2007 ; 164: 1379-1384
54. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet. 1999 ; 88: 83-87
55. Stoltenberg SF, Twitchell GR, Hanna GL, et al. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am J Med Genet. 2002 ; 114: 230-234
56. Singal R, Ginder GD. DNA methylation. Blood. 1999 ; 93: 4059-4070
57. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002 ; 16: 6-21
58. Naveh-Many T, Cedar H. Active gene sequences are undermethylated. Proc Natl Acad Sci USA. 1981 ; 78: 4246-4250
59. Kress C, Thomassin H, Grange T. Local DNA demethylation in vertebrates: How could it be performed and targeted?. FEBS Lett. 2001 ; 494: 135-140
60. Deng C, Lu Q, Zhang Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 2003 ; 48: 746-756
61. Sawalha AH, Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+T cells in MRL/lpr lupus-prone mice. Eur J Immunol. 2007 ; 37: 1407-1413
62. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol. 1995 ; 154: 3025-3035
63. Sawalha AH, Jeffries M, Webb R, et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 2008 ; 9: 368-378
64. Gorelik G, Richardson B. Aberrant T cell ERK pathway signaling and chromatin structure in lupus. Autoimmun Rev. 2009 ; 8: 196-198
65. Eyre H, Baune BT. Neuroplastic changes in depression: A role for the immune system. Psychoneuroendocrinology. 2012 ; 37: 1397-1416